Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000981670 | SCV001129653 | likely benign | not provided | 2024-12-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000981670 | SCV003805968 | uncertain significance | not provided | 2023-02-06 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Revvity Omics, |
RCV000981670 | SCV003828174 | likely benign | not provided | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004973224 | SCV005568947 | likely benign | Inborn genetic diseases | 2024-10-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004543661 | SCV004767881 | likely benign | COL4A1-related disorder | 2022-11-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |